Dr. Olufemi R. Ayeni, MD, PhD, FRCSC
Claim this profileMcMaster University
Studies Stress Fractures
Studies Hip Arthroscopy
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Olufemi R. Ayeni, MD, PhD, FRCSC is currently running
AMIC Surgery
for Hip Cartilage Injury
This is a pilot multi-centre RCT of 40 patients (ages 18-55 years, inclusive) undergoing primary hip arthroscopy with a focal articular cartilage defect of the acetabulum to compare the effect of using autologous matrix-induced chondrogenesis (AMIC) in comparison to microfracture on hip function, health-related quality of life, hip pain, cartilage regeneration, health utility, and any adverse events at 2 years. Follow-up will occur at 6 weeks, 6 months, 12 months, 18 months, and 24 months post-surgery.
Recruiting1 award Phase 1
Quadriceps vs. Hamstring Autograft
for ACL Rupture
To date, the use of the quadriceps tendon as an autograft option in primary paediatric Anterior Cruciate Ligament (ACL) reconstruction has not been well studied. The 2018 International Olympic Committee (IOC) Consensus Statement now outlines the quadriceps tendon as a possible autograft option. However, no Randomised Control Trial (RCT) has examined the efficacy of the quadriceps tendon autograft in primary paediatric ACL reconstruction compared to the historical "gold-standard" soft-tissue hamstring autograft in this population. In light of its evidence for favourable outcomes in the adult population, and the (albeit limited) evidence showing safety and promise in the paediatric population, clinical equipoise exists for assessing its impact on outcomes in paediatric patients at the index surgery. This trial aims to demonstrate feasibility of a global RCT that will evaluate the efficacy of soft-tissue quadriceps versus hamstring autograft tendons on re-operation, return to sport, and knee function among paediatric patients undergoing primary ACL reconstruction.
Recruiting1 award N/A7 criteria
More about Olufemi R. Ayeni, MD, PhD, FRCSC
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Olufemi R. Ayeni, MD, PhD, FRCSC has experience with
- Autologous Matrix-induced Chondrogenesis (AMIC)
- Quadriceps Tendon Autograft
- Soft Tissue Hamstring Autograft
Breakdown of trials Olufemi R. Ayeni, MD, PhD, FRCSC has run
Stress Fractures
Hip Arthroscopy
Articular Cartilage Injury
Microfractures
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Olufemi R. Ayeni, MD, PhD, FRCSC specialize in?
Olufemi R. Ayeni, MD, PhD, FRCSC focuses on Stress Fractures and Hip Arthroscopy. In particular, much of their work with Stress Fractures has involved treating patients, or patients who are undergoing treatment.
Is Olufemi R. Ayeni, MD, PhD, FRCSC currently recruiting for clinical trials?
Yes, Olufemi R. Ayeni, MD, PhD, FRCSC is currently recruiting for 2 clinical trials in Hamilton Ontario. If you're interested in participating, you should apply.
Are there any treatments that Olufemi R. Ayeni, MD, PhD, FRCSC has studied deeply?
Yes, Olufemi R. Ayeni, MD, PhD, FRCSC has studied treatments such as Autologous matrix-induced chondrogenesis (AMIC), Quadriceps tendon autograft, Soft tissue hamstring autograft.
What is the best way to schedule an appointment with Olufemi R. Ayeni, MD, PhD, FRCSC?
Apply for one of the trials that Olufemi R. Ayeni, MD, PhD, FRCSC is conducting.
What is the office address of Olufemi R. Ayeni, MD, PhD, FRCSC?
The office of Olufemi R. Ayeni, MD, PhD, FRCSC is located at: McMaster University, Hamilton, Ontario L8N3Z5 Canada. This is the address for their practice at the McMaster University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.